Santen and Sydnexis partner on childhood myopia treatment SYD-101
Santen and Sydnexis have announced an exclusive agreement to license SYD-101, an investigational treatment for progressive childhood myopia, in Europe, Middle East a...
Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.
Continue readingExploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.
Continue readingExploring emerging approaches to neurodegenerative disease research and treatment.
Continue readingHighlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
Advertisement